New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th
Neurology April 01,2024
Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th
Neurology April 01,2024
PET scans for Alzheimer's could bring benefit to more patients

PET scans for Alzheimer's could bring benefit to more patients

by Ryan O'hare,Imperial College LondonPET scans can spot amyloid in the brain (pictured). Credit: Imperial College LondonAn imaging tool honed to spot rogue proteins in the brain could benef
Neurology April 01,2024
PET scans for Alzheimer's could bring benefit to more patients

PET scans for Alzheimer's could bring benefit to more patients

by Ryan O'hare,Imperial College LondonPET scans can spot amyloid in the brain (pictured). Credit: Imperial College LondonAn imaging tool honed to spot rogue proteins in the brain could benef
Neurology April 01,2024
Promising Alzheimer's research takes a step forward

Promising Alzheimer's research takes a step forward

by University of LiverpoolCredit: University of LiverpoolScientists from the University of Liverpool and Victoria University of Wellington have been awarded over £478K to advance a potential trea
Neurology April 01,2024
Promising Alzheimer's research takes a step forward

Promising Alzheimer's research takes a step forward

by University of LiverpoolCredit: University of LiverpoolScientists from the University of Liverpool and Victoria University of Wellington have been awarded over £478K to advance a potential trea
Neurology April 01,2024
On Nutrition: Food for thoughts

On Nutrition: Food for thoughts

by Barbara IntermillCredit: Unsplash/CC0 Public DomainI forgot that June was Brain Health Awareness Month. And then I stumbled over several interesting research articles that say it's never to lat
Neurology April 01,2024
On Nutrition: Food for thoughts

On Nutrition: Food for thoughts

by Barbara IntermillCredit: Unsplash/CC0 Public DomainI forgot that June was Brain Health Awareness Month. And then I stumbled over several interesting research articles that say it's never to lat
Neurology April 01,2024
MS treatment that 'resets' immune system may halt disease progression for at least five years

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped
Neurology April 01,2024
MS treatment that 'resets' immune system may halt disease progression for at least five years

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped
Neurology April 01,2024
Type 1 IFNs may mediate Zika pregnancy complications

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I
Public Health & Prevention April 01,2024
Type 1 IFNs may mediate Zika pregnancy complications

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I
Public Health & Prevention April 01,2024
The Last of Us: Why making fungal vaccines is so challenging

The Last of Us: Why making fungal vaccines is so challenging

by Rebecca A. Drummond,The ConversationFungus Infected Frog. Credit: Wikipedia CommonsWarning: this article may contain spoilers.HBO's hit TV adaptation of the popular video game "The L
Public Health & Prevention April 01,2024
The Last of Us: Why making fungal vaccines is so challenging

The Last of Us: Why making fungal vaccines is so challenging

by Rebecca A. Drummond,The ConversationFungus Infected Frog. Credit: Wikipedia CommonsWarning: this article may contain spoilers.HBO's hit TV adaptation of the popular video game "The L
Public Health & Prevention April 01,2024
The antibodies of 'post-treatment HIV controllers'

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte
Public Health & Prevention April 01,2024
The antibodies of 'post-treatment HIV controllers'

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte
Public Health & Prevention April 01,2024
'Self-sabotage' prevents immune protection against malaria

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse
Public Health & Prevention April 01,2024
'Self-sabotage' prevents immune protection against malaria

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse
Public Health & Prevention April 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com